Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimagrumab PoC in sarcopenia
NCT01601600Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bimagrumab in Sarcopenia, sponsored by Novartis. Started Jan 2012; status: completed.
02
Drugs
bimagrumab
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT01601600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601600.